1Friedman SL. Liver fibrosis- from bench to bedside. J Hepatol,2003, 38(suppl 1): S38-S53.
2Grotendorst GR. Connective tissue growth factor: a mediator of TGF-bata action on fibroblasts. Cytokine Growth Factor Rev, 1997,8: 171-179.
3Yokoi H, Mukoyama M, Nagae T, et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol , 2004,15 :1430-1440.
4Stratton R, Rajkumar V, Ponticos M, et al. Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras/MEK/ERK pathway. FASEB J ,2002, 16: 1949-1951.
5Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology , 1999,30: 968-976.
6Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9 :347-351.
7Zender L, Hutker S, Liedtke C, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA, 2003, 100: 7797-7802.
